We thank Watsky and Warshaw for their interest and insightful comments. As they point out, ACD was not listed as an adverse effect of treatment with topical hydrocortisone in our commentary.1 We did not mention the potential adverse effect of ACD to topical hydrocortisone because it did not play a role in the debate regarding the appropriateness of permitting OTC sale of topical hydrocortisone preparations.
Eaglstein WH, Ravis SM. Allergic Contact Dermatitis: Another Adverse Effect of Over-the-counter Topical Hydrocortisone—Reply. Arch Dermatol. 2007;143(9):1209-1226. doi:10.1001/archderm.143.9.1217-b